Alopecia in Three Women of Southeast Asian Descent with Chronic Renal Failure: Possible Association with Erythropoietin Use

The document describes a case series of three Southeast Asian women with chronic renal failure who developed significant hair loss after using recombinant human erythropoietin (Epo) to treat anemia. Two of the women showed a clear temporal relationship between starting Epo treatment and the onset of alopecia, and one of them experienced hair regrowth after stopping Epo, suggesting a potential connection between Epo use and hair loss. However, the authors note that other factors such as renal failure, medication use, and various health conditions could also have contributed to the alopecia. They emphasize the need for further research to clarify the impact of Epo on hair in patients with chronic renal failure.